Axsome sells fast-acting depression medicine Auvelity.
Axsome Therapeutics, Inc. (AXSM) is expected to report earnings on Monday, November 2, 2026, before the open. Estimated release time 07:08 ET. Consensus EPS estimate is $-0.57.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-10 | Jun 2026 qtr | $-0.89 | $-0.99 | -11.0% | $218.38M |
| 2026-05-04 | Mar 2026 qtr | $-0.85 | $-1.26 | — | $191.20M |
| 2026-02-23 | Dec 2025 qtr | $-0.70 | $-0.56 | — | $196.00M |
| 2025-11-03 | Sep 2025 qtr | $-0.82 | $-0.94 | -14.6% | $170.99M |
| 2025-08-04 | Jun 2025 qtr | $-1.00 | $-0.97 | +3.0% | $150.04M |
| 2025-05-05 | Mar 2025 qtr | $-1.26 | $-1.22 | +3.2% | $121.46M |
| 2025-02-18 | Dec 2024 qtr | $-1.00 | $-1.54 | — | $118.77M |
| 2024-11-12 | Sep 2024 qtr | $-1.38 | $-1.34 | +2.9% | $104.76M |
AXSM has beaten consensus EPS in 3 of its last 5 scored quarters.
See AXSM on the live calendar →